Alison K Shea, Jennifer Blake, Kaitlyn Treleaven, Leticia Hernandez-Galan
{"title":"Treatment Gaps in the Management of Genitourinary Syndrome of Menopause.","authors":"Alison K Shea, Jennifer Blake, Kaitlyn Treleaven, Leticia Hernandez-Galan","doi":"10.1016/j.jogc.2025.103129","DOIUrl":null,"url":null,"abstract":"<p><p>Genitourinary syndrome of menopause (GSM) affects most postmenopausal women and gender diverse persons (GDP). Many will notice symptoms prior to the cessation of menstruation, related to declining hormone levels. Our aim was to assess GSM incidence among those referred to a specialized Canadian menopause clinic, and to identify potential gaps in care. Among 529 participants, 74% reported bothersome vaginal dryness, but only 10.9% had been prescribed a local vaginal hormone prior to referral. With long wait times for menopause clinics, our results highlight an important area for education for all providers caring for women and GDP in midlife and menopause.</p>","PeriodicalId":520287,"journal":{"name":"Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC","volume":" ","pages":"103129"},"PeriodicalIF":0.0000,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.jogc.2025.103129","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Genitourinary syndrome of menopause (GSM) affects most postmenopausal women and gender diverse persons (GDP). Many will notice symptoms prior to the cessation of menstruation, related to declining hormone levels. Our aim was to assess GSM incidence among those referred to a specialized Canadian menopause clinic, and to identify potential gaps in care. Among 529 participants, 74% reported bothersome vaginal dryness, but only 10.9% had been prescribed a local vaginal hormone prior to referral. With long wait times for menopause clinics, our results highlight an important area for education for all providers caring for women and GDP in midlife and menopause.